Clearmind Medicine Inc.

NASDAQ: CMND · Real-Time Price · USD
1.03
0.01 (0.98%)
At close: Aug 15, 2025, 3:59 PM
1.03
0.00%
After-hours: Aug 15, 2025, 07:10 PM EDT

Clearmind Medicine Cash Flow Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Net Income
-5.25M -6.23M -9.41M -3.9M
Depreciation & Amortization
51.07K 41.59K 113.38K 2.57K
Stock-Based Compensation
883.87K 366.4K 887.3K 500.24K
Other Working Capital
-195.06K -253.23K 441.42K -317.61K
Other Non-Cash Items
-512.7K 210.72K 836.94K 189.69K
Deferred Income Tax
103.88K 17.37K 40.75K n/a
Change in Working Capital
-130.11K -703.89K 1.69M 25.99K
Operating Cash Flow
-4.86M -6.3M -5.08M -2.84M
Capital Expenditures
n/a n/a -7.59K -231.19K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-350.4K n/a n/a -20K
Sales Maturities Of Investments
78.5K n/a n/a n/a
Other Investing Acitivies
33.8K -26.23K -7.59M -14.65K
Investing Cash Flow
-238.1K -26.23K -7.59K -251.19K
Debt Repayment
-42.59K -40.92K -96.54 n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.1M 438.01K 697.98M n/a
Financial Cash Flow
6.25M 8.43M 698.4K 7.36M
Net Cash Flow
1.15M 3.83M -4.42M 4.29M
Free Cash Flow
-4.86M -6.3M -5.09M -3.07M